Table 2.

Clinical outcomes of patients with COVID-19

	Overall (n=299)	Normal liver function throughout (n=165)	Abnormal liver function on or during course of admission (n=134)	P value
Supplemental oxygen via nasal cannula, face mask or venturi, n (%)	190 (63.5)	114 (69.1)	76 (56.7)	0.074
Ventilatory support, n (%)	61 (20.4)	17 (10.3)	44 (32.8)	<0.001
Admission to high dependency or intensive care, n (%)	64 (21.4)	18 (10.9)	46 (34.3)	<0.001
Length of hospital stay, days	9.34±11.4	7.41±6.20	11.7±15.3	<0.001
In-hospital mortality, n (%)	99 (33.1)	62 (37.6)	37 (27.6)	0.723

Data are presented as n (%) and mean±SD.

P values refer to the comparison between patients with or without liver function derangement. P values <0.05 are in bold.

In multivariate analyses, the following covariates were included: age, ethnicity, sex, comorbidity profile (hypertension, diabetes, chronic respiratory disease, cardiac disease and immunosuppression) and medication (ACE inhibitor, angiotensin II receptor blocker, antibiotics and lopinavir–ritonavir).